Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of “Hold” by Brokerages

Omnicell, Inc. (NASDAQ:OMCL) has been assigned an average recommendation of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $37.83.

OMCL has been the topic of several research analyst reports. Benchmark reissued a “buy” rating and set a $38.00 target price on shares of Omnicell in a research note on Monday, July 15th. Bank of America boosted their target price on Omnicell from $34.00 to $44.00 and gave the stock a “buy” rating in a report on Friday, August 2nd. JPMorgan Chase & Co. upped their target price on Omnicell from $26.00 to $37.00 and gave the stock a “neutral” rating in a research report on Friday, August 23rd. StockNews.com cut Omnicell from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, Wells Fargo & Company upped their price objective on Omnicell from $26.00 to $30.00 and gave the company an “equal weight” rating in a report on Friday, August 2nd.

Institutional Trading of Omnicell

Several large investors have recently added to or reduced their stakes in OMCL. Charles Schwab Investment Management Inc. raised its holdings in Omnicell by 7.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 483,443 shares of the company’s stock worth $18,192,000 after acquiring an additional 32,548 shares during the period. Dimensional Fund Advisors LP boosted its stake in Omnicell by 2.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,067,516 shares of the company’s stock valued at $40,173,000 after purchasing an additional 21,798 shares during the period. Panagora Asset Management Inc. acquired a new stake in Omnicell in the 4th quarter valued at approximately $1,319,000. Norges Bank bought a new stake in shares of Omnicell in the fourth quarter valued at approximately $18,802,000. Finally, Ontario Teachers Pension Plan Board raised its stake in Omnicell by 65.8% during the 4th quarter. Ontario Teachers Pension Plan Board now owns 36,211 shares of the company’s stock valued at $1,363,000 after purchasing an additional 14,367 shares during the last quarter. 97.70% of the stock is owned by institutional investors.

Omnicell Trading Up 1.5 %

Omnicell stock opened at $43.42 on Friday. Omnicell has a 1 year low of $25.12 and a 1 year high of $55.58. The firm’s 50-day moving average is $38.85 and its 200-day moving average is $32.12. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.22 and a current ratio of 2.45. The company has a market cap of $2.00 billion, a P/E ratio of -94.39, a PEG ratio of 47.22 and a beta of 0.83.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.37. The firm had revenue of $276.80 million during the quarter, compared to the consensus estimate of $254.41 million. Omnicell had a positive return on equity of 2.52% and a negative net margin of 1.92%. The firm’s revenue was down 7.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.29 EPS. On average, equities analysts expect that Omnicell will post 0.64 earnings per share for the current year.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.